<DOC>
	<DOCNO>NCT01126229</DOCNO>
	<brief_summary>The investigator aim conduct randomize placebo control pilot study determine whether resveratrol , dietary ingredient , supplementation safe improve memory physical performance old adult . Loss memory physical performance frequent complaint old adult grow public health issue . Additionally , later adulthood associate normative decline work primary memory well domains include attention , speed processing executive function . Resveratrol safely tolerate pre-clinical model dose-escalation human study . It also demonstrate beneficial effect memory performance pre-clinical model . Therefore , study take next step understand longer-term safety ( 3 month ) efficacy resveratrol supplementation age-related health condition .</brief_summary>
	<brief_title>Resveratrol Improved Performance Elderly</brief_title>
	<detailed_description>Enrolled participant complete psychological questionnaire multi-measure cognitive test battery , physical function , well provide blood sample , determine blood chemistry . These include complete blood count complete metabolic count [ ( Na , K , Cl , CO2 , BUN , Creatinine , Glucose , Total Protein , Albumin , Calcium , Phosphorous , Aspartate Aminotransferase ( AST ) , Alkaline Phos , Total Bilirubin , Alanine Amino Transferase ( ALT ) ] others deem necessary study physician . They return laboratory perform muscular endurance test MRI evaluation Brain Institute . Eligible participant randomly assign equal probability either receive resveratrol ( 300 mg/d 1000 mg/d ) placebo twelve week . Immediately follow completion MRI , participant give month 's supply resveratrol placebo . All participant closely monitor safety toxicity first 10 day ( range 8-12 day acceptable ) trial . During initial evaluation period , blood chemistry ( complete metabolic profile ) evaluate every 3 ( range 1-2 day acceptable ) day . Following one month , participant ask return clinic . At monthly visit , memory test , blood sample collect monitor cognitive adaptation ensure adverse change occur . Participants ' compliance supplementation regimen also check pill count , participant give month 's supply product monthly visit . After 12 week take either resveratrol placebo daily basis , participant complete final test battery , MRI scan , blood draw collection . A follow-up evaluation provide 10 30 day follow completion final post-treatment assessment .</detailed_description>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Men woman age 65100 year Body mass index &gt; = 25 &lt; = 35 Willing able participate aspect study Willing randomize either treatment group Sedentary moderately active lifestyle ( &lt; 120 min aerobic activity/week ) Report ability walk one mile MMSE &gt; 24 Nonsmoking Telephone Interview cognitive status ( TICS ) Active treatment cancer , stroke ( &lt; 6 mo ) , peripheral vascular disease , coronary artery disease ( myocardial infarction &lt; 6 mo ) , state III , IV Congestive Heart Failure , valvular heart disease , major psychiatric disease , severe anemia , liver renal disease , diabetes , severe osteoarthritis , blindness deafness , fracture upper low extremity within last 6 month , upper low extremity amputation , anticoagulant therapy ( aspirin use permit ) , parkinson disease Failure give consent Anabolic medication ( growth hormone testosterone ) High amount physical activity ( i.e . running , bicycle etc ) &gt; 120 min/week . Dementing illness Excessive alcohol use ( &gt; 2 drink per day ) Resting heart rate &gt; 120 bpm Systolic blood pressure &gt; 180 mmHg Diastolic blood pressure &gt; 100 mmHg Dietary supplementation grape seed extract ginko biloba History significant head injury Vision hearing impairment Anticholinesterase inhibitor ( Aricept ) Contraindications MRI ( e.g . cardiac pacemaker , implanted cardiac defibrillator , aneurysm clip , claustrophobia , etc . ) Consumption red wine/dealcoholized red wine/red purple grape juice weekly ; consumption dietary supplement contain resveratrol , quercetin , P. cuspidatum previous 90 day ; Subject participate another clinical trial receive investigational product within 30 day prior screening/enrollment Current Use Antidepressant Medications CESD Score &gt; 20</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Resveratrol</keyword>
	<keyword>Grape</keyword>
	<keyword>Aging</keyword>
	<keyword>functional MRI ( fMRI )</keyword>
	<keyword>Anti-Aging therapeutic</keyword>
	<keyword>Oxidative Stress</keyword>
	<keyword>Functional Performance</keyword>
</DOC>